Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyLearn more
Comprehensive Medicine Department · Cancer Hospital of Chinese Academy of Medical Sciences · Beijing

Dr. Wang Yanfeng王延风

Chief Physician

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Wang Yanfeng

Professional overview

Dr. Wang Yanfeng is a Chief Physician in the Comprehensive Medicine Department at Cancer Hospital of Chinese Academy of Medical Sciences, specializing in comprehensive management of advanced lung cancer with multi-organ metastases and targeted therapies for specific genetic mutations.

SpecialtyComprehensive Medicine Department
Clinical titleChief Physician
Academic roles—
DepartmentComprehensive Medicine Department
HospitalCancer Hospital of Chinese Academy of Medical Sciences
CityBeijing

Areas of focus

Lung cancerComprehensive treatment of advanced lung cancer with malignant pleural effusion, brain metastasis, bone metastasis, liver metastasis, and other multi-organ metastases
Targeted therapyTargeted treatment for EGFR, ALK, KRAS G12C, ROS1, MET, and RET mutations
Clinical trialsAssessment of novel drug clinical research
Immune-related adverse eventsComprehensive management of immune checkpoint inhibitor-related adverse reactions

Experience & recognition

  • Published over 20 papers in core journals and SCI-indexed journals
  • Reviewer for the Chinese Medical Journal and Chinese Journal of Clinical Doctors
  • Participated in the development of multiple clinical consensus guidelines

Professional roles

  • Council Member, Geriatric Oncology Society, Chinese Gerontological Society (CGOS)
  • Member, Oncology Rehabilitation Branch, Chinese Gerontological Society
  • Member, Chinese Medical Association

Frequently asked questions

What does Dr. Wang Yanfeng specialize in?

Comprehensive management of advanced lung cancer with multi-organ metastases (including malignant pleural effusion, brain metastasis, bone metastasis, liver metastasis), targeted therapy for EGFR, ALK, KRAS G12C, ROS1, MET, and RET mutations, assessment of novel drug clinical research, and comprehensive management of immune checkpoint inhibitor-related adverse reactions

Which hospital and department is Dr. Wang Yanfeng in?

Comprehensive Medicine Department at Cancer Hospital of Chinese Academy of Medical Sciences

Sources

Dr. Wang Yanfeng has not reviewed this page.